Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OrganiGram Holdings ( (TSE:OGI) ) has provided an update.
Organigram posted strong first-quarter fiscal 2026 results, with gross revenue rising 46% to $97.3 million and net revenue up 49% to $63.5 million, driven by the Motif Labs acquisition and higher international sales. The company retained leading Canadian market share across key product categories, boosted adjusted EBITDA to $5.3 million, and turned a $20 million net profit from a loss a year earlier on improved margins and financial instrument revaluations.
Operationally, Organigram expanded its U.S. footprint to 11 states with its Collective Project and Fetch brands while flagging that recent U.S. federal hemp law changes could force a restructuring of its hemp-derived THC activities by late 2026 if not reversed. The firm also reported a 43% increase in harvested kilograms and a genetic breakthrough in powdery mildew resistance that should enhance yield stability and reduce production costs, underscoring its emphasis on efficiency, plant science and international growth under new CEO James Yamanaka.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is primarily weighed down by weak profitability and negative operating/free cash flow despite solid revenue growth and a low-leverage balance sheet. Technical indicators also lean bearish (below key moving averages and negative MACD), and valuation support is limited because the company is loss-making and has no dividend yield provided.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a Canadian cannabis producer and marketer, positioned as the country’s largest cannabis company by market share. It focuses on adult-use and medical cannabis products including vapes, milled flower, concentrates, pre-rolls, edibles and dried flower, and is expanding its presence in the U.S. and international markets.
Average Trading Volume: 316,294
Technical Sentiment Signal: Sell
Current Market Cap: C$283.5M
For detailed information about OGI stock, go to TipRanks’ Stock Analysis page.